Juno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms – Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Our goal is to revolutionize medicine by re-engaging the body’s immune system to treat cancer.

Download DocumentationJuno Corporate Presentation - September 2016
Webcast ImageWebcast - Replay
Juno Therapeutics at Morgan Stanley Global Healthcare Conference
September 13, 2016 at 12:20 p.m. ET
Juno Therapeutics at Morgan Stanley Global Healthcare Conference
Tuesday, September 13, 2016 12:20 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast - Live
Juno Therapeutics at Leerink Partners Rare Disease & Immuno-Oncology Roundtable
September 29, 2016 at 12:30 p.m. ET
Juno Therapeutics at Leerink Partners Rare Disease & Immuno-Oncology Roundtable
Thursday, September 29, 2016 12:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Recent News

DateTitle 
Sep. 07, 2016CORRECTING and REPLACING JCAR014 Clinical Data Published in Science Translational Medicine: Patients with Advanced Lymphoma in Remission after T-cell TherapyPrinter Friendly Version
Sep. 07, 2016JCAR014 Clinical Data Published in Science Translational Medicine: Patients with Advanced Lymphoma in Remission after T-cell TherapyPrinter Friendly Version
Sep. 06, 2016Juno Therapeutics to Present at September 2016 Investor ConferencesPrinter Friendly Version
Aug. 04, 2016Juno Therapeutics Reports Second Quarter 2016 Financial ResultsPrinter Friendly Version

Upcoming Events

DateTitle
Sep. 29, 2016
12:30 p.m. ET
Juno Therapeutics at Leerink Partners Rare Disease & Immuno-Oncology Roundtable

Past Events

DateTitle
09/13/16 12:20 p.m. ET
Juno Therapeutics at Morgan Stanley Global Healthcare Conference
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
JUNO (Common Stock)
ExchangeNASDAQ
Price$29.65
Change0.00 (0.00%)
Volume0
Data as of Sep. 26, 2016 4:00 p.m. ET